Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where B. Puerto is active.

Publication


Featured researches published by B. Puerto.


Ultrasound in Obstetrics & Gynecology | 2008

Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation

O. Gómez; F. Figueras; S. Fernandez; M. Bennasar; J. M. Martínez; B. Puerto; Eduard Gratacós

To construct gestational age (GA)‐based reference ranges for the uterine artery (UtA) mean pulsatility index (PI) at 11–41 weeks of pregnancy.


Ultrasound in Obstetrics & Gynecology | 2005

Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population

O. Gómez; J. M. Martínez; F. Figueras; M. del Río; V. Borobio; B. Puerto; Oriol Coll; V. Cararach; J. A. Vanrell

To establish reference values for the first‐trimester uterine artery (UtA) pulsatility index (PI) and to investigate the role of UtA Doppler in the early prediction of hypertensive disorders and their associated complications in an unselected Mediterranean population.


Ultrasound in Obstetrics & Gynecology | 2006

Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome.

O. Gómez; F. Figueras; J. M. Martínez; M. del Río; M. Palacio; Elisenda Eixarch; B. Puerto; Oriol Coll; V. Cararach; J. A. Vanrell

To describe sequential changes in uterine artery waveform between the first and second trimesters of gestation and to analyze their association with the subsequent risk of hypertensive disorders and fetal growth restriction (IUGR).


American Journal of Reproductive Immunology | 2001

Risk Factors Associated with Fetal Losses in Treated Antiphospholipid Syndrome Pregnancies: A Multivariate Analysis

Francisco Carmona; Marcos Azulay; Montserrat Creus; Francisco Fábregues; B. Puerto; Juan Balasch; José Font; Ricardo Cervera

PROBLEM: Pregnancies in women with antiphospholipid syndrome (APS) are associated with obstetric complications despite treatment. The present study analyzes risk factors and evaluates fetal outcome in a large sample of treated APS pregnancies.
 METHOD OF STUDY: Seventy‐seven pregnancies in 56 women were included. Twelve selected variables potentially related to the outcome of treated pregnancies were analyzed in a multivariate logistic regression model.
 RESULTS: Treated women delivered 65 live infants at 24–41 weeks gestation (mean 36.7±0.5) but two neonatal deaths occurred. There were seven first‐trimester miscarriages (9%) and five intrauterine fetal demises (6.5%). Thus, the probability of having a live baby under treatment was 82% (95% CI 71.3–89.6%), a figure significantly greater (P<0.001) than that observed before therapy (25.7%; 95% CI 18.7–33.7%). Variables related with fetal outcome in the multivariate model were: preconceptional use of aspirin and abnormal umbilical artery Doppler velocimetry at 23–26 weeks gestation.
 CONCLUSIONS: The present report shows that in treated APS pregnancies: i) aspirin treatment started preconceptionally is an independent and significant prognostic factor associated with favorable fetal outcome; and ii) abnormal velocity waveforms in the umbilical artery predict adverse outcome of pregnancy.


Ultrasound in Obstetrics & Gynecology | 2008

Doppler assessment of the aortic isthmus and perinatal outcome in preterm fetuses with severe intrauterine growth restriction

M. del Río; J. M. Martínez; F. Figueras; M. Bennasar; A. Olivella; M. Palacio; Oriol Coll; B. Puerto; Eduard Gratacós

To evaluate the characteristics and association with perinatal outcome of the aortic isthmus (AoI) circulation as assessed by Doppler imaging in preterm growth‐restricted fetuses with placental insufficiency.


Journal of Assisted Reproduction and Genetics | 2001

The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.

Juan Balasch; Montserrat Creus; Francisco Fábregues; Salvadora Civico; Francisco Carmona; B. Puerto; Roser Casamitjana; Juan A. Vanrell

Purpose: The purpose of this prospective, randomized study was to compare ovarian response and oocyte and embryo yields in women undergoing ovulation induction for IVF/ICSI using recombinant human FSH (rhFSH) alone or in combination with recombinant human LH (rhLH).Methods: Patients were randomized to receive rhFSH alone (group F; n = 13) or rhFSH + rhLH (group L; n = 15). rhFSH was administered according to a step-down protocol; patients assigned to group L received rhLH at a fixed dose of 75 IU (1 ampoule) throughout the treatment period.Results: The total dose of rhFSH, number of growing follicles, and serum concentrations of estradiol (E2) on the day of hCG administration were similar in both treatment groups. However, the percentage of metaphase II oocytes and fertilization rate were significantly higher in group F than in group L. The lower fertilization rates associated with rhLH were also seen in a subgroup of patients from group L who had undergone a previous ART cycle stimulated with FSH only and thus acted as their own controls. However, when in vitro fertilization (IVF) and intracytoplasmic sperm injection cycles were considered separately, differences in fertilization rates were statistically significant only for oocytes treated by conventional IVF.Conclusions: This study shows that the addition of recombinant LH to recombinant FSH in pituitary-suppressed women undergoing ART does not improve the ovarian response and even may have a negative impact on oocyte maturation and fertilization.


Ultrasound in Obstetrics & Gynecology | 2010

Accuracy of four-dimensional spatiotemporal image correlation echocardiography in the prenatal diagnosis of congenital heart defects

M. Bennasar; J. M. Martínez; O. Gómez; J. Bartrons; A. Olivella; B. Puerto; Eduard Gratacós

To evaluate the accuracy of four‐dimensional (4D) spatiotemporal image correlation (STIC) echocardiography for the diagnosis of fetal congenital heart disease (CHD) in a selected high‐risk population.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 2003

Cardiac function monitoring of fetuses with growth restriction

Francesc Figueras; B. Puerto; Josep M. Martinez; V. Cararach; Juan A. Vanrell

OBJECTIVE To describe the time sequence of changes in cardiac function in intrauterine growth restriction. STUDY DESIGN This was a prospective longitudinal study on 22 singleton pregnancies with growth-restricted fetuses. Pulsatility indices of fetal arterial and venous Doppler waveforms, systolic peak velocity in the aorta and pulmonary artery, right and left ventricular shortening fraction and atrioventricular flow E/A ratio were assessed at each monitoring session. Logistic regression was used for modeling the probability of abnormality of a variable in relation to the time interval before delivery. Trends over time were analyzed by Mann-Withney U-test. RESULTS Umbilical artery pulsatility index was the first variable to become abnormal, followed by the middle cerebral artery, right diastolic indices (right E/A, ductus venosus), right systolic indices and, finally, both diastolic and systolic left cardiac indices. CONCLUSION We have found an earlier and more pronounced right than left and diastolic than systolic fetal cardiac function deterioration in growth restricted fetuses monitored longitudinally.


Ultrasound in Obstetrics & Gynecology | 2006

Prenatal diagnosis and outcome for fetuses with congenital absence of the pulmonary valve.

Alberto Galindo; F. Gutiérrez-Larraya; J. M. Martínez; M. del Río; A. Grañeras; J. M. Velasco; B. Puerto; Eduard Gratacós

To analyze fetal echocardiographic findings of absent pulmonary valve syndrome (APVS), its association with chromosomal and extracardiac anomalies including nuchal translucency (NT) and the outcome after diagnosis.


Ultrasound in Obstetrics & Gynecology | 2006

Reference ranges for Doppler parameters of the fetal aortic isthmus during the second half of pregnancy

M. del Río; J. M. Martínez; F. Figueras; Marta López; M. Palacio; O. Gómez; Oriol Coll; B. Puerto

To establish reference ranges for blood flow velocity waveforms (FVW) of the fetal aortic isthmus (AoI) during the second and third trimesters of pregnancy.

Collaboration


Dive into the B. Puerto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

O. Gómez

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Bennasar

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Figueras

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

M. del Río

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

V. Cararach

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge